GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy
Authors: André J. Scheen
Published: 2024-09-28
DOI:
10.1007/s40265-024-02090-9
Source:
Full article
Abstract
No abstract found.